Example: Heart Attack

Clinical Trials on Factor VII Deficiency

Total 7 results





    • NCT03079063
      Recruiting
      Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency
      Conditions: Factor VII Deficiency
    • NCT01269138
      Completed
      Treatment of Inherited Factor VII Deficiency
      Conditions: Factor VII Deficiency
    • NCT02470871
      Completed
      Study of the Pharmacokinetics and Safety of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) in Patients With Congenital Factor VII Deficiency
      Conditions: Congenital Coagulation Factor VII Deficiency
    • NCT01779921
      Completed
      Treatment of Congenital Factor VII Deficiency
      Conditions: Congenital Bleeding Disorder; Congenital FVII Deficiency
    • NCT04548791
      Not yet recruiting
      Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders
      Conditions: Factor VII Deficiency; Glanzmann Thrombasthenia; Hemophilia A With Inhibitor
    • NCT03372993
      Enrolling by invitation
      Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven
      Conditions: Hemophilia A With Inhibitor; Hemophilia B With Inhibitor; Factor VII Deficiency; Glanzmann's Thrombasthenia
    • NCT00697320
      Completed
      Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
      Conditions: Congenital Bleeding Disorder; Congenital FVII Deficiency; Glanzmann's Disease; Acquired Bleeding Disorder; Acquired Haemophilia
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations